Journal
MOLECULAR PSYCHIATRY
Volume 14, Issue 9, Pages 885-893Publisher
SPRINGERNATURE
DOI: 10.1038/mp.2008.30
Keywords
allele; dopamine; haplotype; linkage disequilibrium; PBAT
Funding
- NARSAD
- Mental Health Research Association
- United States National Institute of Mental Health (MTT) [1R01MH059624]
- National Health Research Institute of Taiwan [90-8825PP, 91,92-9113PP]
- National Taiwan University Hospital
- Medical College of National Taiwan University
- National Taoyuan Psychiatric Center
- National Tsaotun Psychiatric Center
- National Cheng-Kung University
- Kai-Suan Psychiatric Hospital of Kaohsiung City
- Yu-Li Veterans Hospital
- National Yu-Li Hospital
Ask authors/readers for more resources
The gene that codes for dopamine receptor D2 (DRD2 on chromosome 11q23) has long been a prime functional and positional candidate risk gene for schizophrenia. Collectively, prior case-control studies found a reliable effect of the Ser311Cys DRD2 polymorphism (rs1801028) on risk for schizophrenia, but few other polymorphisms in the gene had ever been evaluated and no adequately powered family-based association study has been performed to date. Our objective was to test 21 haplotype-tagging and all three known nonsynonymous single-nucleotide polymorphisms (SNPs) in DRD2 for association with schizophrenia in a family-based study of 2408 Han Chinese, including 1214 affected individuals from 616 families. We did not find a significant effect of rs1801028, but we did find significant evidence for association of schizophrenia with two multi-marker haplotypes spanning blocks of strong linkage disequilibrium (LD) and nine individual SNPs (Ps < 0.05). Importantly, two SNPs (rs1079727 and rs2283265) and both multi-marker haplotypes spanning entire LD blocks (including one that contained rs1801028) remained significant after correcting for multiple testing. These results further add to the body of data implicating DRD2 as a schizophrenia risk gene; however, a causal variant(s) in DRD2 remains to be elucidated by further fine mapping of the gene, with particular attention given to the area surrounding the third through fifth exons. Molecular Psychiatry (2009) 14, 885-893; doi: 10.1038/mp.2008.30; published online 11 March 2008
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available